- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kodak concludes Lumisys acquisition
The purchase of Lumisys by Eastman Kodak went through in late December. The deal provides Kodak with a new line of desktop computed radiography systems and x-ray film digitizers, as well as radiology portal AuntMinnie.com. Kodak acquired the capital
The purchase of Lumisys by Eastman Kodak went through in late December. The deal provides Kodak with a new line of desktop computed radiography systems and x-ray film digitizers, as well as radiology portal AuntMinnie.com. Kodak acquired the capital stock of Lumisys for a cash exchange of $4.05 per share, totaling about $39 million.
With the closing of the deal, Lumisys becomes a Kodak subsidiary. AuntMinnie.com remains a subsidiary of Lumisys. The Web portal, according to Kodak, will operate as an independent unit. Lumisys adds its desktop unit ACR-2000 system to Kodak's existing CR portfolio, namely the Kodak DirectView CR 800 System for distributed image processing, and Kodak DirectView CR 900 System for centralized image processing. The Lumiscan Film Digitizer offers an alternative to Kodak customers as they transition to digital imaging.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
